Adam Wierzbowski, a BLB&G partner, represents shareholders in investor litigations throughout the United States. A respected and prolific litigator, Adam has prosecuted some of the most significant shareholder cases in U.S. history, recovering billions of dollars for damaged investors. He practices out of BLB&G’s New York office.
Adam’s work has included successes at the trial and appellate levels in several high-profile class actions. These include the following recoveries on behalf of investors:
- In re Fannie Mae/Freddie Mac Senior Preferred Stock Purchase Agreement Class Action Litigations: Leading the BLB&G trial team to a successful jury verdict, and $812 million recovery for investors, in the case arising out of the federal government’s decision to sweep the net worth of Fannie Mae and Freddie Mac to the U.S. Treasury.
- In re Merck Vioxx Securities Litigation: Serving as a senior member of the team that recovered $1.06 billion on behalf of investors in the securities litigation against Merck arising out of defendants’ alleged misrepresentations about the cardiovascular safety of the painkiller Vioxx.The case settled just months before trial and after a unanimous victory for investors at the U.S. Supreme Court.
- UnitedHealth Group, Inc. Shareholder Derivative Litigation: Helping to recover in excess of $920 million from individual defendants in this derivative action involving executives’ illegal backdating of stock options.
- In re Schering-Plough Corp./ENHANCE Securities Litigation and In re Merck & Co., Inc. Vytorin/Zetia Securities Litigation: Serving as a senior member of the team that achieved total settlements of $688 million on behalf of investors in cases related to Schering and Merck’s alleged misrepresentations about anti-cholesterol drugs Vytorin and Zetia.
- Gary Hefler et al. v. Wells Fargo & Company et al.: Co-leading the team that obtained $480 million for investors in the securities class action against Wells Fargo & Co. related to its fake accounts scandal.
- New York State Teachers' Retirement System v. General Motors Company: Achieving a $300 million recovery in the securities class action against General Motors stemming from the company’s delayed recall of vehicles with defective ignition switches.
Adam also helped to obtain significant recoveries on behalf of investors in Minneapolis Firefighters’ Relief Association v. Medtronic, Inc. et al. ($85 million recovery); In re Myriad Genetics, Inc. Securities Litigation ($77.5 million recovery); and Key West Police & Fire Pension Fund v. Ryder System, Inc. ($45 million recovery).
Adam has been recognized by various publications for his accomplishments as an up-and-coming lawyer. He has been named to Benchmark Litigation’s “40 & Under Hot List,” Lawdragon’s “500 Leading Plaintiff Financial Lawyers” list, and Thomson Reuter’s Super Lawyers New York Metro edition, earning a designation as a New York “Rising Star.”
Adam received his J.D., with honors, from the George Washington University Law School, where he served as notes editor for The George Washington International Law Review. He received his B.A., magna cum laude, from Dartmouth College.